LeadIQ logo
Learn more at LeadIQ.com

Insights

Loading spinner
Gathering insights about Cadent Therapeutics

Similar companies to Cadent Therapeutics

Cadent Therapeutics Tech Stack

Cadent Therapeutics uses 8 technology products and services including SAS, WordPress, Font Awesome, and more. Explore Cadent Therapeutics's tech stack below.

  • SAS
    Business Intelligence
  • WordPress
    Content Management System
  • Font Awesome
    Font Scripts
  • Chart.js
    Javascript Graphics
  • Lightbox
    Javascript Libraries
  • Yoast SEO
    Search Engines
  • Google Tag Manager
    Tag Management
  • Nginx
    Web Servers

Media & News

Cadent Therapeutics's Email Address Formats

Cadent Therapeutics uses at least 1 format(s):
Cadent Therapeutics Email FormatsExamplePercentage
FLast@cadenttx.comJDoe@cadenttx.com
50%
FLast@cadenttx.comJDoe@cadenttx.com
50%

Frequently Asked Questions

Where is Cadent Therapeutics's headquarters located?

Minus sign iconPlus sign icon
Cadent Therapeutics's main headquarters is located at 60 Hamilton St Cambridge, Massachusetts 02139 US. The company has employees across 1 continents, including North America.

What is Cadent Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Cadent Therapeutics's official website is cadenttx.com and has social profiles on LinkedIn.

What is Cadent Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Cadent Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Cadent Therapeutics have currently?

Minus sign iconPlus sign icon
As of December 2020, Cadent Therapeutics has approximately 25 employees across 1 continents, including North America. Key team members include Chief Executive Officer: J. M.Chief Medical Officer: C. K.Chief Financial Officer: J. M.. Explore Cadent Therapeutics's employee directory with LeadIQ.

What industry does Cadent Therapeutics belong to?

Minus sign iconPlus sign icon
Cadent Therapeutics operates in the Biotechnology Research industry.

What technology does Cadent Therapeutics use?

Minus sign iconPlus sign icon
Cadent Therapeutics's tech stack includes SASWordPressFont AwesomeChart.jsLightboxYoast SEOGoogle Tag ManagerNginx.

What is Cadent Therapeutics's email format?

Minus sign iconPlus sign icon
Cadent Therapeutics's email format typically follows the pattern of . Find more Cadent Therapeutics email formats with LeadIQ.

How much funding has Cadent Therapeutics raised to date?

Minus sign iconPlus sign icon
As of December 2020, Cadent Therapeutics has raised $55M in funding. The last funding round occurred on Nov 15, 2018 for $40M.

When was Cadent Therapeutics founded?

Minus sign iconPlus sign icon
Cadent Therapeutics was founded in 2017.
Cadent Therapeutics

Cadent Therapeutics

Biotechnology ResearchMassachusetts, United States11-50 Employees

Cadent Therapeutics is a precision neuroscience company with a mission to discover and develop innovative treatments to restore brain rhythms and improve outcomes in patients living with movement, mood, and cognitive disorders. 

Currently in early clinical development, Cadent is rapidly advancing its pipeline of therapies to treat spinocerebellar ataxia, essential tremor and schizophrenia. Investors include Atlas Venture, Clal Biotechnology Industries, Slater Technology Fund. Cowen, Qiming Venture Partners, Access Industries, and Novartis. 

For more information, please visit cadenttx.com.

Section iconCompany Overview

Headquarters
60 Hamilton St Cambridge, Massachusetts 02139 US
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2017
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $55M

    Cadent Therapeutics has raised a total of $55M of funding over 2 rounds. Their latest funding round was raised on Nov 15, 2018 in the amount of $40Mas a Series B.

Section iconFunding & Financials

  • $55M

    Cadent Therapeutics has raised a total of $55M of funding over 2 rounds. Their latest funding round was raised on Nov 15, 2018 in the amount of $40Mas a Series B.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.